文献
J-GLOBAL ID:201802279051224907
整理番号:18A0976611
肺腺癌におけるサルベージ療法は,第一線ゲフィチニブおよび第二線細胞毒性化学療法に起因する感受性EGFR突然変異および後天性抵抗性を示す【JST・京大機械翻訳】
The salvage therapy in lung adenocarcinoma initially harbored susceptible EGFR mutation and acquired resistance occurred to the first-line gefitinib and second-line cytotoxic chemotherapy
著者 (21件):
Yang Chih-Jen
(Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan)
,
Yang Chih-Jen
(Division of Pulmonary and Critical Care Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan)
,
Yang Chih-Jen
(Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan)
,
Yang Chih-Jen
(Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan)
,
Hung Jen-Yu
(Division of Pulmonary and Critical Care Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan)
,
Hung Jen-Yu
(Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan)
,
Tsai Ming-Ju
(Division of Pulmonary and Critical Care Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan)
,
Wu Kuan-Li
(Division of Pulmonary and Critical Care Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan)
,
Wu Kuan-Li
(Division of Chest Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan)
,
Liu Ta-Chih
(Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan)
,
Liu Ta-Chih
(Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan)
,
Chou Shah-Hwa
(Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan)
,
Chou Shah-Hwa
(Department of Medical Imaging, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan)
,
Lee Jui-Ying
(Department of Medical Imaging, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan)
,
Hsu Jui-Sheng
(Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan)
,
Hsu Jui-Sheng
(Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan)
,
Huang Ming-Shyan
(Division of Pulmonary and Critical Care Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan)
,
Huang Ming-Shyan
(Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan)
,
Huang Ming-Shyan
(Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan)
,
Chong Inn-Wen
(Division of Pulmonary and Critical Care Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan)
,
Chong Inn-Wen
(Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan)
資料名:
BMC Pharmacology and Toxicology (Web)
(BMC Pharmacology and Toxicology (Web))
巻:
18
号:
1
ページ:
21
発行年:
2017年
JST資料番号:
U7310A
ISSN:
2050-6511
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)